Vaccination with CD133 + melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor

Cancer Immunology, Immunotherapy

Volumn 60, Issue 11, 2011, Pages 1597-1608

  Miyabayashi, Takao ^a   Kagamu, Hiroshi ^a   Koshio, Jun ^a   Ichikawa, Kosuke ^a   Baba, Junko ^a   Watanabe, Satoshi ^a   Tanaka, Hiroshi ^b   Tanaka, Junta ^b   Yoshizawa, Hirohisa ^b   Nakata, Koh ^b   Narita, Ichiei ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Antitumor immunotherapy; Cancer stem cells; CD133; Melanoma; Th17

Indexed keywords

CD133 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CELL STIMULATION; CELL SUBPOPULATION; CELL THERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; EFFECTOR CELL; ERADICATION THERAPY; FEMALE; IMMUNOGENICITY; IMMUNOREACTIVITY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TH1 CELL; TH17 CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; GLYCOPROTEINS; IMMUNOTHERAPY, ACTIVE; IMMUNOTHERAPY, ADOPTIVE; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PEPTIDES; T-LYMPHOCYTES; TH1 CELLS; TH17 CELLS;

EID: 82355182087     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1063-x     Document Type: Article

References (34)

1. SK Singh C Hawkins ID Clarke JA Squire J Bayani T Hide RM Henkelman MD Cusimano PB Dirks 2004 Identification of human brain tumour initiating cells Nature 432 396 401 15549107 10.1038/nature03128 1:CAS:528:DC%2BD2cXpvVCjtbY%3D (Pubitemid 39551674)
2. C Li DG Heidt P Dalerba CF Burant L Zhang V Adsay M Wicha MF Clarke DM Simeone 2007 Identification of pancreatic cancer stem cells Cancer Res 67 1030 1037 17283135 10.1158/0008-5472.CAN-06-2030 1:CAS:528:DC%2BD2sXht1yns70%3D
3. L Ricci-Vitiani DG Lombardi E Pilozzi M Biffoni M Todaro C Peschle R De Maria 2007 Identification and expansion of human colon-cancer-initiating cells Nature 445 111 115 17122771 10.1038/nature05384 1:CAS:528:DC%2BD2sXhsFOmug%3D%3D (Pubitemid 46067311)
4. CA O'Brien A Pollett S Gallinger JE Dick 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 106 110 17122772 10.1038/nature05372 (Pubitemid 46067310)
5. T Schatton GF Murphy NY Frank K Yamaura AM Waaga-Gasser M Gasser Q Zhan S Jordan LM Duncan C Weishaupt, et al. 2008 Identification of cells initiating human melanomas Nature 451 345 349 18202660 10.1038/nature06489 1:CAS:528:DC%2BD1cXnt1Gisg%3D%3D
6. M Mimeault SK Batra 2007 Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications Cancer Metastasis Rev 26 203 214 17273942 10.1007/s10555-007-9052-4 1:CAS:528:DC%2BD2sXjt1Kqtbc%3D (Pubitemid 46452192)
7. M Diehn MF Clarke 2006 Cancer stem cells and radiotherapy: new insights into tumor radioresistance J Natl Cancer Inst 98 1755 1757 17179471 10.1093/jnci/djj505 (Pubitemid 46017927)
8. NY Frank A Margaryan Y Huang T Schatton AM Waaga-Gasser M Gasser MH Sayegh W Sadee MH Frank 2005 ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma Cancer Res 65 4320 4333 15899824 10.1158/0008-5472.CAN-04-3327 1:CAS:528:DC%2BD2MXktlSmt7Y%3D (Pubitemid 40775671)
9. E Monzani F Facchetti E Galmozzi E Corsini A Benetti C Cavazzin A Gritti A Piccinini D Porro M Santinami, et al. 2007 Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential Eur J Cancer 43 935 946 17320377 10.1016/j.ejca.2007.01.017 1:CAS:528:DC%2BD2sXisleitLg%3D (Pubitemid 46366698)
10. S Bao Q Wu RE McLendon Y Hao Q Shi AB Hjelmeland MW Dewhirst DD Bigner JN Rich 2006 Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 756 760 17051156 10.1038/nature05236 1:CAS:528:DC%2BD28Xht1OntbzP (Pubitemid 44949604)
11. I Malanchi H Peinado D Kassen T Hussenet D Metzger P Chambon M Huber D Hohl A Cano W Birchmeier, et al. 2008 Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling Nature 452 650 653 18385740 10.1038/nature06835 1:CAS:528:DC%2BD1cXktFCgsLY%3D (Pubitemid 351483363)
12. M Copland A Hamilton LJ Elrick JW Baird EK Allan N Jordanides M Barow JC Mountford TL Holyoake 2006 Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction Blood 107 4532 4539 16469872 10.1182/blood-2005-07-2947 1:CAS:528:DC%2BD28Xlt1CgtrY%3D (Pubitemid 43801382)
13. HD Hemmati I Nakano JA Lazareff M Masterman-Smith DH Geschwind M Bronner-Fraser HI Kornblum 2003 Cancerous stem cells can arise from pediatric brain tumors Proc Natl Acad Sci USA 100 15178 15183 14645703 10.1073/pnas.2036535100 1:CAS:528:DC%2BD3sXpvFaqu70%3D (Pubitemid 37518036)
14. G Rappa O Fodstad A Lorico 2008 The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma Stem Cells 26 3008 3017 18802032 10.1634/stemcells.2008-0601 1:CAS:528: DC%2BD1MXhtFSktrg%3D
15. SV Sharma DY Lee B Li MP Quinlan F Takahashi S Maheswaran U McDermott N Azizian L Zou MA Fischbach, et al. 2010 A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations Cell 141 69 80 20371346 10.1016/j.cell.2010.02.027 1:CAS:528:DC%2BC3cXlsVSgtb8%3D
16. H Kagamu S Shu 1998 Purification of L-selectin (low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes J Immunol 160 3444 3452 9531305 1:CAS:528:DyaK1cXitFWlur0%3D (Pubitemid 28164738)
17. N Fujita H Kagamu H Yoshizawa K Itoh H Kuriyama N Matsumoto T Ishiguro J Tanaka E Suzuki H Hamada, et al. 2001 CD40 ligand promotes priming of fully potent antitumor CD4(+) T cells in draining lymph nodes in the presence of apoptotic tumor cells J Immunol 167 5678 5688 11698440 1:CAS:528: DC%2BD3MXotlamtLs%3D (Pubitemid 33062758)
18. T Hiura H Kagamu S Miura A Ishida H Tanaka J Tanaka F Gejyo H Yoshizawa 2005 Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression J Immunol 175 5058 5066 16210609 1:CAS:528:DC%2BD2MXhtVylsbjK (Pubitemid 41456389)
19. S Watanabe H Kagamu H Yoshizawa N Fujita H Tanaka J Tanaka F Gejyo 2003 The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity J Immunol 171 5828 5836 14634092 1:CAS:528:DC%2BD3sXptFOksrs%3D (Pubitemid 37467199)
20. H Kagamu JE Touhalisky GE Plautz JC Krauss S Shu 1996 Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes Cancer Res 56 4338 4342 8813119 1:CAS:528:DyaK28XmtVyltro%3D (Pubitemid 26330433)
21. N Martin-Orozco P Muranski Y Chung XO Yang T Yamazaki S Lu P Hwu NP Restifo WW Overwijk C Dong 2009 T helper 17 cells promote cytotoxic T cell activation in tumor immunity Immunity 31 787 798 19879162 10.1016/j.immuni.2009. 09.014 1:CAS:528:DC%2BD1MXhsFylsbjJ
22. I Kryczek S Wei W Szeliga L Vatan W Zou 2009 Endogenous IL-17 contributes to reduced tumor growth and metastasis Blood 114 357 359 19289853 10.1182/blood-2008-09-177360 1:CAS:528:DC%2BD1MXovVKlsr0%3D
23. K Koyama H Kagamu S Miura T Hiura T Miyabayashi R Itoh H Kuriyama H Tanaka J Tanaka H Yoshizawa, et al. 2008 Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+CD4+ regulatory T cells in small cell lung cancer reflects disease stage Clin Cancer Res 14 6770 6779 18980970 10.1158/1078-0432.CCR-08-1156 1:CAS:528:DC%2BD1cXhtlens7jN
24. Y Miyahara K Odunsi W Chen G Peng J Matsuzaki RF Wang 2008 Generation and regulation of human CD4+IL-17-producing T cells in ovarian cancer Proc Natl Acad Sci USA 105 15505 15510 18832156 10.1073/pnas.0710686105 1:CAS:528:DC%2BD1cXht1Gnt73P
25. E Bettelli Y Carrier W Gao T Korn TB Strom M Oukka HL Weiner VK Kuchroo 2006 Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 235 238 16648838 10.1038/nature04753 1:CAS:528:DC%2BD28XksVGns7g%3D
26. RM Steinman S Turley I Mellman K Inaba 2000 The induction of tolerance by dendritic cells that have captured apoptotic cells J Exp Med 191 411 416 10662786 10.1084/jem.191.3.411 1:CAS:528:DC%2BD3cXhtV2isbw%3D
27. D Hawiger K Inaba Y Dorsett M Guo K Mahnke M Rivera JV Ravetch RM Steinman MC Nussenzweig 2001 Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo J Exp Med 194 769 779 11560993 10.1084/jem.194.6.769 1:CAS:528:DC%2BD3MXmvFGgsrY%3D (Pubitemid 32983013)
28. W Zou NP Restifo 2010 T(H)17 cells in tumour immunity and immunotherapy Nat Rev Immunol 10 248 256 20336152 10.1038/nri2742 1:CAS:528: DC%2BC3cXjvVGlt7k%3D
29. G Shi CA Cox BP Vistica C Tan EF Wawrousek I Gery 2008 Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells J Immunol 181 7205 7213 18981142 1:CAS:528:DC%2BD1cXhtlaisrjP
30. M Numasaki J Fukushi M Ono SK Narula PJ Zavodny T Kudo PD Robbins H Tahara MT Lotze 2003 Interleukin-17 promotes angiogenesis and tumor growth Blood 101 2620 2627 12411307 10.1182/blood-2002-05-1461 1:CAS:528: DC%2BD3sXivVWgu70%3D (Pubitemid 36857622)
31. L Wang T Yi M Kortylewski DM Pardoll D Zeng H Yu 2009 IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway J Exp Med 206 1457 1464 19564351 10.1084/jem.20090207 1:CAS:528:DC%2BD1MXos1eis7k%3D
32. KS Sfanos TC Bruno CH Maris L Xu CJ Thoburn AM DeMarzo AK Meeker WB Isaacs CG Drake 2008 Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing Clin Cancer Res 14 3254 3261 18519750 10.1158/1078-0432.CCR-07-5164 1:CAS:528:DC%2BD1cXmslygs70%3D
33. I Kryczek M Banerjee P Cheng L Vatan W Szeliga S Wei E Huang E Finlayson D Simeone TH Welling, et al. 2009 Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments Blood 114 1141 1149 19470694 10.1182/blood-2009-03-208249 1:CAS:528: DC%2BD1MXhtVSgsbbE
34. E von Euw T Chodon N Attar J Jalil RC Koya B Comin-Anduix A Ribas 2009 CTLA4 blockade increases Th17 cells in patients with metastatic melanoma J Transl Med 7 35 10.1186/1479-5876-7-35